A Case of sustained complete response of advanced cutaneous Squamous Cell Cancer of the scalp to Cemiplimab

Cutaneous Squamous Cell Cancer (cSCC) is the second most common Non-Melanoma Skin Cancer (NMSC) after basal cell in the United States with increasing incidence due to advanced age and screening. It predominantly occurs in the head and neck region (scalp, face, ears, lips, nose, neck e.t.c) with chronic Ultra-Violet (UV) radiation from repeated sun exposure and immunosuppression being the main risk factor.